S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Options trading has suddenly become more reliable. (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Top 5 Tech Stocks to Buy for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Options trading has suddenly become more reliable. (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Top 5 Tech Stocks to Buy for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Options trading has suddenly become more reliable. (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Top 5 Tech Stocks to Buy for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
Options trading has suddenly become more reliable. (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Top 5 Tech Stocks to Buy for 2024 (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NYSEARCA:PBE

Invesco Biotechnology & Genome ETF (PBE) Price, Holdings, & News

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free PBE Stock Alerts
$59.62
-0.94 (-1.55%)
(As of 04/18/2024 ET)
Compare
Today's Range
$59.60
▼
$60.51
50-Day Range
$59.62
▼
$67.29
52-Week Range
$52.47
▼
$67.76
Volume
8,056 shs
Average Volume
12,141 shs
Market Capitalization
$226.56 million
Assets Under Management
$229.44 million
Dividend Yield
0.06%
Net Expense Ratio
0.58%
Stock AnalysisChartHeadlinesHoldingsOwnershipRatings
PBE stock logo

About Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund’s investment adviser.

PBE Stock Price History

PBE ETF News Headlines

March 22, 2024 | msn.com
Invesco Dynamic Biotechnology & Genome ETF declares quarterly distribution of $0.0242
February 19, 2024 | investorplace.com
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
February 14, 2024 | msn.com
Where Are Biotech ETFs Headed After Q4 Earnings?
December 22, 2023 | uk.investing.com
Invesco MSCI USA ESG Universal Screened UCITS ETF USD Distribution
December 14, 2023 | uk.investing.com
Invesco Markets plc - Invesco S&P China A 300 Swap UCITS ETF
November 27, 2023 | lse.co.uk
Invesco Nasdaq Biotech Ucits Etf Share Price (SBIO.AM)
November 25, 2023 | wsj.com
Invesco Biotechnology & Genome ETF
April 18, 2024 | DTI (Ad)
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
November 16, 2023 | lse.co.uk
Invesco Msci World Esg Screen Ucits Etf Share Price (ESGW.MI)
See More Headlines
Receive PBE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Invesco
Fund Name
Invesco Biotechnology & Genome ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:PBE
Inception Date
6/23/2005
Fund Manager
Peter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser
Web
www.invescopowershares.com
Phone
+1-800-9830903

Fund Focus

Asset Class
Equity
Benchmark
Dynamic Biotech & Genome Intellidex Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
31

Fund Statistics

Assets Under Management
$229.44 million
Average Daily Volume
$5,973.50
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Invesco Capital Management LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Invesco Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
N/A
Short Interest
9,000 shs

Miscellaneous

Outstanding Shares
3,800,000
Beta
0.92
Creation Unit
10,000
Creation Fee
$500.00
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Ad DTI
Biden’s $374B Giveaway Into This Sector
Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here
Click here for the full story

Invesco Biotechnology & Genome ETF Expenses

TypePBEHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.56%0.54%0.50%0.51%
Other Expenses0.08%0.40%0.54%0.64%0.58%
Total Expense0.58%0.72%0.70%0.74%0.70%
Fee Waiver0.00%-0.53%-0.55%-0.68%-0.57%
Net Expense0.58%0.60%0.60%0.58%0.58%

Invesco Biotechnology & Genome ETF (PBE) Holdings & Exposure

Top 10 PBE Holdings

PBE Sector Exposure

PBE Industry Exposure

Full Holdings Details

PBE ETF - Frequently Asked Questions

How have PBE shares performed in 2024?

Invesco Biotechnology & Genome ETF's stock was trading at $65.84 at the start of the year. Since then, PBE shares have decreased by 9.4% and is now trading at $59.62.
View the best growth stocks for 2024 here.

What does PBE invest in?

Invesco Biotechnology & Genome ETF is a equity fund issued by Invesco. PBE focuses on health care investments and follows the Dynamic Biotech & Genome Intellidex Index. The fund's investments total to approximately $229.44 million assets under management.

What stocks does Invesco Biotechnology & Genome ETF hold?

PBE invests in 31 holdings. Some of the stocks in their portfolio include Neurocrine Biosciences (NBIX), Bio-Techne (TECH), BioMarin Pharmaceutical (BMRN), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Amgen (AMGN), Biogen (BIIB), MannKind (MNKD) and Collegium Pharmaceutical (COLL).

What is the management fee for Invesco Biotechnology & Genome ETF?

Invesco Biotechnology & Genome ETF's management fee is 0.50% and has other expenses of 0.08%. The net expense ratio for PBE is 0.58%.

What other stocks do shareholders of Invesco Biotechnology & Genome ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Biotechnology & Genome ETF investors own include Pfizer (PFE), Intel (INTC), Align Technology (ALGN), Micron Technology (MU), Activision Blizzard (ATVI), DocuSign (DOCU), Inovio Pharmaceuticals (INO), Mastercard (MA), Hello Group (MOMO) and ONEOK (OKE).

Who are Invesco Biotechnology & Genome ETF's major shareholders?

Invesco Biotechnology & Genome ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Banque Cantonale Vaudoise (0.13%) and Webster Bank N. A. (0.05%).

How do I buy shares of Invesco Biotechnology & Genome ETF?

Shares of PBE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:PBE) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How Biden has already won 2024
Porter & Company